Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia (2025)
- Authors:
- Miranda, Lívia Bassani Lins De
- Martins, Diego Antonio Pereira
- Ramos, Dominique Sternadt Alexandre
- Simões, Luíse Araújo de Albuquerque
- Lima, Keli
- Tomaz, Victoria
- Cortez, Luiz Ferreira
- Silva, Mariana de Franca Basto
- Guedes, Rafael Lucas Muniz
- Traina, Fabiola
- Campregher, Paulo Vidal
- Rego, Eduardo Magalhães
- Schuringa, Jan Jacob
- Machado Neto, João Agostinho
- Miranda, Lívia Bassani Lins De
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; TRAINA, FABÍOLA - FMRP ; MIRANDA, LÍVIA BASSANI LINS DE - ICB ; SIMÕES, LUÍSE ARAÚJO DE ALBUQUERQUE - FM ; LIMA, KELI CRISTINA DE - FM
- Unidades: FM; ICB; FMRP
- DOI: 10.1002/2211-5463.70071
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; MUTAÇÃO GENÉTICA; CÉLULAS CULTIVADAS DE TUMOR; APOPTOSE; PROTEÔMICA; ANTINEOPLÁSICOS; ESTRESSE OXIDATIVO; GLICOSE
- Language: Inglês
- Imprenta:
- Source:
- Título: FEBS Open Bio
- ISSN: 2211-5463
- Volume/Número/Paginação/Ano: v. 15, supl. 2, p. 247-248, res. P-30-084, 2025
- Conference titles: Bridging Continents to Advance Life Science
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MIRANDA, Lívia Bassani Lins De et al. Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia. FEBS Open Bio. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/2211-5463.70071. Acesso em: 21 jan. 2026. , 2025 -
APA
Miranda, L. B. L. D., Martins, D. A. P., Ramos, D. S. A., Simões, L. A. de A., Lima, K., Tomaz, V., et al. (2025). Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia. FEBS Open Bio. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/2211-5463.70071 -
NLM
Miranda LBLD, Martins DAP, Ramos DSA, Simões LA de A, Lima K, Tomaz V, Cortez LF, Silva M de FB, Guedes RLM, Traina F, Campregher PV, Rego EM, Schuringa JJ, Machado Neto JA. Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia [Internet]. FEBS Open Bio. 2025 ; 15 247-248.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1002/2211-5463.70071 -
Vancouver
Miranda LBLD, Martins DAP, Ramos DSA, Simões LA de A, Lima K, Tomaz V, Cortez LF, Silva M de FB, Guedes RLM, Traina F, Campregher PV, Rego EM, Schuringa JJ, Machado Neto JA. Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia [Internet]. FEBS Open Bio. 2025 ; 15 247-248.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1002/2211-5463.70071 - NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
- NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
- Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations
- Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation
- IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]
- DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients
- De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
- Stathmin 1 expression in plasma cell neoplasms. [Carta]
Informações sobre o DOI: 10.1002/2211-5463.70071 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
